Evidence map›Paper›PMID 15342737›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

Chronic morphine treatment reduces recovery from opioid desensitization.

Vu C Dang, John T Williams

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Opioid Pharmacology under the Microscope.Molecular pharmacology · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Postendocytic Sorting of Adrenergic and Opioid Receptors: New Mechanisms and Functions.Progress in molecular biology and translational science · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vu C DangVollum Institute and Department of Physiology and Pharmacology, Oregon Health Sciences University, Portland, Oregon 97239, USA.
John T Williams

Funding

CHRONIC MORPHINE--REGULATION OF ION CONDUCTANCESR01DA008163 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1993 to 2021
$6.2M
NIDA NIH HHS DA08163NIDA NIH HHS R01 DA008163
6 · The paper itself

Abstract

Tolerance and dependence result from long-term exposure to opioids, and there is growing evidence linking acute receptor desensitization to these more long-term processes. Receptor desensitization encompasses a series of events leading to the loss of receptor function and internalization. This study examines the onset and recovery from desensitization in locus ceruleus neurons recorded in brain slices taken from animals that have been chronically treated with morphine. After chronic morphine treatment, desensitization was altered as follows. First, the rate of desensitization was increased. Second, recovery from desensitization was always incomplete, even after a brief (1-2 min) exposure to agonist. This contrasts with experiments in controls in which recovery from desensitization, after a brief exposure to agonist, was complete within 25 min. Finally, morphine-6-beta-D-glucuronide, a metabolite of morphine that was ineffective at causing desensitization in controls, induced significant desensitization in slices from morphine-treated animals. When brain slices from controls were treated with inhibitors of PKC or monensin, agents known to compromise G-protein-coupled receptor resensitization, desensitization was increased, and recovery was significantly reduced. These results indicate that receptor resensitization maintains signaling during periods of intense and sustained stimulation. After chronic morphine treatment, desensitization is potentiated, and receptor resensitization is compromised.

Indexed as

Adrenergic alpha-AgonistsAnimalsBrimonidine TartrateCocaineDrug ToleranceEnkephalin, MethionineLeucineLocus CoeruleusMaleMonensinMorphineMorphine DependenceMorphine DerivativesNorepinephrinePhosphorylationPrazosinAdrenergic alpha-AgonistsBrimonidine TartrateCocaineEnkephalin, MethionineLeucineMonensinMorphinemorphine-6-glucuronideMorphine DerivativesNorepinephrinePrazosinProtein Kinase CQuinoxalinesReceptors, Adrenergic, alpha-2Receptors, Opioid, muStaurosporineThiorphanubenimexYohimbine

Identifiers

PMID15342737
PMCPMC3631536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.